July 30, 2014 9:18 AM ET

Capital Markets

Company Overview of Bay City Capital LLC

Executive Profile

Ross Bersot CFA

Chief Executive Officer, President and Director, Reset Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background

Mr. Ross Bersot, CFA, serves as a Managing Director and Investment Partner at Bay City Capital LLC. He has been with the firm since September 2002 and focuses on investment opportunities in visionary biopharmaceutical and enabling technology companies. Mr. Bersot serves as the Chief Executive Officer and President of Reset Therapeutics, Inc. and founded the company in 2008. As part of the Pritzker Research Consortia Business Strategy team, Mr. Bersot works to commercialize ...

Corporate Headquarters

750 Battery Street
San Francisco, California 94111

United States

Phone: 415-676-3830
Fax: 415-837-0503

Board Members Memberships

Director
Chief Executive Officer, President and Director

Education

BA
University of California-Los Angeles

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Bay City Capital LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.